BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12889598)

  • 1. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray.
    Swami S; Raghavachari N; Muller UR; Bao YP; Feldman D
    Breast Cancer Res Treat; 2003 Jul; 80(1):49-62. PubMed ID: 12889598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
    Narvaez CJ; Welsh J
    Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
    Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
    Simboli-Campbell M; Narvaez CJ; van Weelden K; Tenniswood M; Welsh J
    Breast Cancer Res Treat; 1997 Jan; 42(1):31-41. PubMed ID: 9116316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach.
    Kriebitzsch C; Verlinden L; Eelen G; Tan BK; Van Camp M; Bouillon R; Verstuyf A
    Anticancer Res; 2009 Sep; 29(9):3471-83. PubMed ID: 19667141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
    Campbell MJ; Reddy GS; Koeffler HP
    J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.
    Verlinden L; Verstuyf A; Van Camp M; Marcelis S; Sabbe K; Zhao XY; De Clercq P; Vandewalle M; Bouillon R
    Cancer Res; 2000 May; 60(10):2673-9. PubMed ID: 10825140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.